• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法治疗带状疱疹相关的角膜新生血管化和脂质角膜病变。

Treatment of herpes zoster related corneal neovascularisation and lipid keratopathy by photodynamic therapy.

作者信息

Goh Yi Wei, McGhee Charles Nj, Patel Dipika V, Barnes Rachel, Misra Stuti

机构信息

Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Clin Exp Optom. 2014 May;97(3):274-7. doi: 10.1111/cxo.12110. Epub 2013 Sep 22.

DOI:10.1111/cxo.12110
PMID:24112362
Abstract

Traditionally, photodynamic therapy (PDT) has been used to treat choroidal neovascularisation. More recently, its use in corneal neovascularisation has provided promising clinical results. The major advantage of PDT is that it is minimally invasive, resulting in closure of the neovascular network without damaging the surrounding healthy tissue. This report describes the positive results of PDT, clinically and microstructurally, as imaged by in vivo confocal microscopy, for treating corneal neovascularisation with lipid keratopathy, secondary to herpes zoster infection.

摘要

传统上,光动力疗法(PDT)一直用于治疗脉络膜新生血管。最近,其在角膜新生血管治疗中的应用已取得了令人鼓舞的临床效果。PDT的主要优点是微创,可使新生血管网络闭合,而不损伤周围健康组织。本报告描述了通过体内共聚焦显微镜成像,PDT在治疗继发于带状疱疹感染的脂质角膜病变性角膜新生血管方面的临床和微观结构上的积极效果。

相似文献

1
Treatment of herpes zoster related corneal neovascularisation and lipid keratopathy by photodynamic therapy.光动力疗法治疗带状疱疹相关的角膜新生血管化和脂质角膜病变。
Clin Exp Optom. 2014 May;97(3):274-7. doi: 10.1111/cxo.12110. Epub 2013 Sep 22.
2
Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.光动力疗法治疗角膜新生血管后复发性单纯疱疹性角膜炎。
Cornea. 2010 Apr;29(4):465-7. doi: 10.1097/ICO.0b013e3181b53310.
3
Topographical alteration in the cornea after photodynamic therapy for neovascularization in lipid keratopathy.脂质角膜病变新生血管形成光动力治疗后角膜的地形学改变
Jpn J Ophthalmol. 2009 Nov;53(6):655-657. doi: 10.1007/s10384-009-0739-7. Epub 2009 Dec 18.
4
Photodynamic therapy for corneal neovascularisation and lipid degeneration.用于角膜新生血管化和脂质变性的光动力疗法。
Br J Ophthalmol. 2004 Jun;88(6):840. doi: 10.1136/bjo.2003.035071.
5
Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris.使用PhotoPoint光敏剂MV6401(甲基脱镁叶绿酸铟氯化物)进行光动力疗法,可实现对大鼠角膜新生血管和兔脉络膜毛细血管的选择性封闭。
Br J Ophthalmol. 2005 Jan;89(1):113-9. doi: 10.1136/bjo.2004.043075.
6
Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
Ophthalmic Surg Lasers. 2000 Jan-Feb;31(1):55-60.
7
[Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38 patients].
Klin Monbl Augenheilkd. 2000 Aug;217(2):94-9. doi: 10.1055/s-2000-10391.
8
Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.用维替泊芬光动力疗法实验性抑制角膜新生血管形成
Curr Eye Res. 2006 Mar;31(3):215-24. doi: 10.1080/02713680600559564.
9
[Research status of photodynamic therapy for corneal neovascularization].[角膜新生血管光动力疗法的研究现状]
Zhonghua Yan Ke Za Zhi. 2012 Jul;48(7):662-5.
10
Regression of mature lymphatic vessels in the cornea by photodynamic therapy.光动力疗法使成熟的角膜淋巴管消退。
Br J Ophthalmol. 2014 Mar;98(3):391-5. doi: 10.1136/bjophthalmol-2013-303887. Epub 2014 Jan 10.

引用本文的文献

1
Lipid Keratopathy: A Review of Pathophysiology, Differential Diagnosis, and Management.脂质角膜病变:病理生理学、鉴别诊断及治疗综述
Ophthalmol Ther. 2020 Dec;9(4):833-852. doi: 10.1007/s40123-020-00309-y. Epub 2020 Oct 15.
2
Lipid keratopathy and septal abscess: Case report.脂质角膜病变与鼻中隔脓肿:病例报告
Medicine (Baltimore). 2019 Dec;98(52):e17802. doi: 10.1097/MD.0000000000017802.